BD CD11c (S-HCL-3)APC - HSA Registration DE0509409
Access comprehensive regulatory information for BD CD11c (S-HCL-3)APC in the Singapore medical device market through Pure Global AI's free database. This CLASS C IVD medical device is registered under HSA registration number DE0509409 and owned by Becton, Dickinson & Company. The device was registered on June 18, 2024.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
CD11c (S-HCL-3) is intended for in vitro diagnostic use in the identification of cells expressing CD11c antigen, using a BD FACS™ brand flow cytometer. Clinical applications: expression of the CD11c antigen in the characterization of subjects having, or suspected of having, hematological neoplasia. CD11c (S-HCL- 3) is a qualitative reagent intended for laboratory professional use only.